Black Diamond Therapeutics, Inc.·4

Feb 17, 4:16 PM ET

Buck Elizabeth 4

4 · Black Diamond Therapeutics, Inc. · Filed Feb 17, 2022

Insider Transaction Report

Form 4
Period: 2022-02-15
Buck Elizabeth
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-15+90,00090,000 total
    Exercise: $3.79Exp: 2032-02-14Common Stock (90,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to this option shall vest and become exercisable on February 15, 2023, with the remainder vesting in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    form4-02172022_010238.xmlPrimary